TODROS, Tullia
 Distribuzione geografica
Continente #
NA - Nord America 18.898
EU - Europa 13.929
AS - Asia 5.781
SA - Sud America 752
AF - Africa 202
OC - Oceania 174
Continente sconosciuto - Info sul continente non disponibili 24
Totale 39.760
Nazione #
US - Stati Uniti d'America 18.410
IT - Italia 3.076
CN - Cina 2.540
IE - Irlanda 1.514
DE - Germania 1.499
SE - Svezia 1.458
SG - Singapore 1.224
FR - Francia 1.144
DK - Danimarca 1.126
UA - Ucraina 894
FI - Finlandia 838
KR - Corea 722
GB - Regno Unito 543
PL - Polonia 470
CA - Canada 287
VN - Vietnam 283
BR - Brasile 255
ES - Italia 250
TR - Turchia 209
NL - Olanda 189
IN - India 181
AT - Austria 167
MX - Messico 164
CL - Cile 157
AU - Australia 154
JP - Giappone 141
CO - Colombia 139
BE - Belgio 136
ID - Indonesia 128
PT - Portogallo 108
RU - Federazione Russa 99
GR - Grecia 88
AR - Argentina 81
PE - Perù 70
CH - Svizzera 69
TW - Taiwan 61
SN - Senegal 60
HK - Hong Kong 52
RO - Romania 42
NO - Norvegia 35
IL - Israele 34
IR - Iran 34
CZ - Repubblica Ceca 32
EC - Ecuador 29
ZA - Sudafrica 29
PH - Filippine 26
HU - Ungheria 25
TH - Thailandia 25
EU - Europa 24
HR - Croazia 22
NZ - Nuova Zelanda 20
ET - Etiopia 18
NG - Nigeria 18
EG - Egitto 17
LT - Lituania 15
SI - Slovenia 15
UZ - Uzbekistan 14
BA - Bosnia-Erzegovina 13
BY - Bielorussia 12
SA - Arabia Saudita 12
SK - Slovacchia (Repubblica Slovacca) 12
MU - Mauritius 10
RS - Serbia 10
GH - Ghana 9
MY - Malesia 9
PA - Panama 9
QA - Qatar 9
YE - Yemen 9
CY - Cipro 8
EE - Estonia 7
KH - Cambogia 7
VE - Venezuela 7
BO - Bolivia 6
DZ - Algeria 6
IQ - Iraq 6
NI - Nicaragua 6
PK - Pakistan 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
GT - Guatemala 5
MA - Marocco 5
UG - Uganda 5
UY - Uruguay 5
BG - Bulgaria 4
JM - Giamaica 4
JO - Giordania 4
KE - Kenya 4
LK - Sri Lanka 4
LU - Lussemburgo 4
PS - Palestinian Territory 4
SV - El Salvador 4
TZ - Tanzania 4
AL - Albania 3
CI - Costa d'Avorio 3
KW - Kuwait 3
KZ - Kazakistan 3
LB - Libano 3
LV - Lettonia 3
MK - Macedonia 3
OM - Oman 3
Totale 39.723
Città #
Ann Arbor 2.492
Chandler 2.049
Beijing 1.729
Dublin 1.483
Houston 1.452
Santa Clara 1.137
Singapore 979
Fairfield 642
Jacksonville 624
Villeurbanne 619
Torino 611
Medford 523
Ashburn 521
Princeton 468
Woodbridge 449
Dearborn 432
Wilmington 428
Columbus 408
Warsaw 367
Nyköping 302
Redwood City 283
Seattle 267
Milan 260
Cambridge 237
Pisa 208
Boston 174
Boardman 169
Dong Ket 146
Fremont 120
Santiago 113
Guangzhou 108
Vienna 108
Verona 105
Turin 96
Rome 92
Toronto 85
Norwalk 84
Jakarta 69
Shanghai 69
Brussels 67
Nanjing 63
Hefei 50
Falls Church 47
New York 47
Bogotá 46
Lachine 45
Phoenix 45
San Diego 45
Taipei 45
Hamburg 41
São Paulo 41
Istanbul 40
Munich 40
Los Angeles 37
Kunming 36
Pune 36
London 32
Ottawa 31
Paris 31
Helsinki 30
Mountain View 29
Shenyang 29
Sydney 29
Lima 28
Madrid 28
Wuhan 27
Des Moines 26
Berlin 25
Jinan 25
Buenos Aires 24
Hangzhou 24
Gent 23
Amsterdam 22
Dallas 22
Medellín 22
Nürnberg 22
Silver Spring 22
Athens 21
Bologna 21
Düsseldorf 21
Izmir 20
Washington 20
Brisbane 19
Chengdu 19
Hanoi 19
Hebei 19
Moscow 19
Nanchang 19
Tokyo 19
Chicago 18
Ankara 17
Barcelona 17
Florence 17
Fuzhou 17
Hong Kong 17
Palermo 17
Piacenza 17
Xian 17
Baltimore 16
Central District 16
Totale 22.252
Nome #
Vegan-vegetarian diets in pregnancy: Danger or panacea? A systematic narrative review 2.483
FIGO consensus guidelines on intrapartum fetal monitoring: Cardiotocography 1.355
Lithium prophylaxis during pregnancy and the postpartum period in women with lithium-responsive bipolar I disorder 588
Pregnancy e-health: a multicenter Italian cross-sectional study on internet use and decision-making among pregnant women 493
Pregnancy epigenetic signature in T helper 17 and T regulatory cells in multiple sclerosis 392
Vegan-vegetarian low-protein supplemented diets in pregnant CKD patients: Fifteen years of experience 365
Nemo syndrome (incontinentia pigmenti) and systemic lupus erythematosus: a new disease association. 328
Aberrant TGFβ signalling contributes to dysregulation of sphingolipid metabolism in intrauterine growth restriction 323
Percorso diagnostico terapeutico assistenziale dell'epilessia. 313
FIGO consensus guidelines on intrapartum fetal monitoring: Physiology of fetal oxygenation and the main goals of intrapartum fetal monitoring 312
Pro-inflammatory profile of preeclamptic placental mesenchymal stromal cells: new insights into the etiopathogenesis of preeclampsia. 299
Helicobacter pylori seropositivity and pregnancy-related diseases: A prospective cohort study 295
Kidney biopsy in pregnancy: evidence for counselling? A systematic narrative review. 288
Feto-placental vascularization: A multifaceted approach. 261
JunB/Cyclin-D1 imbalance in placental mesenchymal stromal cells derived from preeclamptic pregnancies with fetal-placental compromise. 260
Chronic kidney disease may be differentially diagnosed from preeclampsia by serum biomarkers 259
[Transverse fetal growth curves. A multicenter study] 246
Association of Low-Protein Supplemented Diets with Fetal Growth in Pregnant Women with CKD. 231
FIGO consensus guidelines on intrapartum fetal monitoring: Intermittent auscultation 226
FIGO consensus guidelines on intrapartum fetal monitoring: Introduction 224
FIGO consensus guidelines on intrapartum fetal monitoring: Adjunctive technologies 220
Istopatologia ed aspetti molecolari: espressione dell’alfa-smooth muscle actin (alfa-sma) in placente fisiologiche ed in placente complicate da Fetal Grewth Restriction (FGR) 218
Reply 218
Vegetarian supplemented low-protein diets. A safe option for pregnant CKD patients: report of 12 pregnancies in 11 patients 209
Is It Possible to Differentiate Chronic Kidney Disease and Preeclampsia by means of New and Old Biomarkers? A Prospective Study 206
Is Helicobacter Pylori infection a risk factor for miscarriage? 196
Transdermal clonidine in the treatment of severe hyperemesis. A pilot randomised control trial: CLONEMESI. 196
Risk of adverse pregnancy outcomes in women with CKD 194
WHAT ABOUT THE CHILDREN BORN TO MOTHERS ON VEGAN LOW-PROTEIN SUPPLEMENTED DIETS IN PREGNANCY? 194
NUOVA APPLICAZIONE TERAPEUTICA DI UN MEZZO CONDIZIONATO DA CELLULE STAMINALI MESENCHIMALI PLACENTARI 194
Differential expression of Tight Junction proteins in preeclamptic placentae 191
Pregnancy and Chronic Kidney Disease: A Challenge in All CKD Stages 187
Characterization of Activator Protein-1 (AP-1) Family Gene Expression in Placental Mesenchymal Stem Cells derived from Normal and Preeclamptic Pregnancies. 187
Multiple Pregnancies in CKD Patients: An Explosive Mix. 180
Hepcidin Expression in Placentae from Preeclamptic Pregnancies with or without Fetal Growth Restriction 178
Amniotic mesenchymal cells from pre-eclamptic placentae maintain immunomodulatory features as healthy controls. 176
Anti-inflammatory and pro-angiogenic effects of placental mesenchymal stromal cells conditioned media on preeclamptic placental tissue. 175
Increased levels of macrophage migration inhibitory factor (MIF) in preeclampsia 174
Placental expression of IGF-1 and IGFBP-3 in pregnancies complicated by fetal growth restriction 172
Infiammazione, NO e preeclampsia 169
Is three-dimensional power Doppler ultrasound useful in the assessment of placental perfusion in normal and growth-restricted pregnancies? 169
Investigation of placental stem villi arteries in fetally growth-restricted pregnancies: a multivariate analysis 166
Helicobacter pylori and pregnancy-related disorders. 163
Pre-eclampsia is associated with Helicobacter pylori seropositivity in Italy 160
Characterization of Decoy Receptors D6 and DUFFY in Preeclamptic Placental Tissues. 158
Un modello di assistenza alla gravidanza fisiologica evidence-based: verifica di efficacia e di efficienza 157
Placental morphometry: correlation with maternal and fetal blood gases in normal and FGR. 156
Espressione placentare di IGF-1 e di IGFBP-3 in casi di preeclampsia con restrizione di crescita fetale 156
Helicobacter pylori’s Virulence and Infection Persistence Define Preeclampsia complicated by Fetal Growth Retardation. 156
Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia 156
INDOLEAMINE-2,3-DEOXYGENASE (IDO1) OXYGEN-MEDIATED REGULATION IN NORMAL, PREECLAMPTIC AND CHRONIC KIDNEY DISEASE (CKD) PLACENTAE 155
Umbilical Doppler waveforms and placental villous angiogenesis in pregnancies complicated by fetal growth restriction. 155
Il neonato VLBW, AGA, SGA e con IUGR: valutazione della crescita 154
Espressione placentare di IGF-1 e IGFBP-3 in casi di preeclampsia con restrizione di crescita fetale 154
Protean presentation and multiple challenges of nephrocalcinosis inpregnancy (six pregnancies in four patients) 153
A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. 153
Localizzazione ed espressione placentare di TGF-b1, TGF-bRI e p-Smad2 in gravidanze complicate da preeclampsia 152
Experimental assessment of human umbilical vein compliance in physiological and IUGR pregnancies 151
Assessing placental vascularization via US volumetric imaging: preliminary results & speculations 150
Over-expression of G1/S and G2/M negative cell cycle regulator p16, p18, p21, p27, LDOC1, PARP1 and Caspase3 in Preeclamptic (PE) Placenta-derived Mesenchymal Stromal Cells (PDMSCs). 150
Sensitivity and specificity of echography in the diagnosis of placental accretism in patients with diagnosis of placenta praevia 150
Twin Pregnancy: A Model of Placental Adaptation 148
New evidence for the role of infection in the pathogenesis of preeclampsia: increased levels of Macrophage migration Inhibitory Factor (MIF) 147
Intrauterine growth restriction: oxygen and placental growth. 147
Evaluation of the placental vascularity using fractal parameters: could they help in early diagnosis of fetal growth restrictions? 147
Twin pregnancy: A model of placental adaptation 145
Evidence for a role of TGF-beta1 in the expression and regulation of alpha-SMA in fetal growth restricted placentae. 145
Expression of alfa-smooth-muscle-actin in the normal and FGR placentas 144
La biobanca di piccolipiu’: una risorsa italiana per la salute dei bambini 144
PLACENTA DERIVED MESENCHYMAL STEM CELLS (PDMSCS) MODULATE HIF-1A, VEGF AND JUNB GENES IN OVARIAN CANCER CELLS. 140
Pathogenesis of intrauterine growth restriction (IUGR)-conclusions derived from a European Union Biomed 2 Concerted Action project 'Importance of Oxygen Supply in Intrauterine Growth Restricted Pregnancies'-a workshop report. 139
The double life of MULE in preeclamptic and IUGR placentae. 139
Nucleated red blood cells in term fetuses: reference values using an automated analyzer. 139
Altered expression of G1/S phase cell cycle regulators in placental mesenchymal stromal cells derived from preeclamptic pregnancies with fetal-placental compromise 136
A Single Sphingomyelin Species Promotes Exosomal Release of Endoglin into the Maternal Circulation in Preeclampsia 136
Dopplervelocimetria ombelicale: le basi fisiopatologiche 135
Placental localization and expressions of TGF-beta1, TGF-betaRI and p-Smad2 in pregnacies complicated by Preeclampsia 134
Sonographic evaluation of overall and regional vascularization of fetal brain: a preliminary methodological study. 134
A best-practice position statement on pregnancy after kidney transplantation: focusing on the unsolved questions. The Kidney and Pregnancy Study Group of the Italian Society of Nephrology 134
Macrophage migration inhibitory factor in human pregnancy and labor. 133
Quantitative Doppler measures in coiled vessels: investigation on excised umbilical veins 131
Macrophage Migration Inhibitory Factor (MIF) In Fetoplacental Tissues From Preeclamptic Pregnancies With Or Without Fetal Growth Restriction. 131
Strategies for preventing group B streptococcal infections in newborns: A nation-wide survey of Italian policies 131
Placental Expression of Soluble fms-Like Tyrosine Kinase 1 is Increased in Singletons and Twin Pregnancies with Intrauterine Growth Restriction. 129
Piccolipiù, a multicenter birth cohort in Italy: protocol of the study. 128
Intrauterine Growth Restriction (IUGR) and thrombophilic polymorphisms 125
Ipodisfibrinogenemia materna e predisposizione alla vasculopatia trombotica fetale: outcome feto-neonatale in due successive gravidanze 125
Should phenotype of previous preterm birth influence management of women with short cervix in subsequent pregnancy? Comparison of vaginal progesterone and Arabin pessary 124
Repeated albumin infusions do not lower blood pressure in preeclampsia. 123
Ginecologia e Ostetricia 123
PLACENTAL CONTRIBUTION TO FETAL NEUROLOGICAL DEVELOPMENT: ROLE OF PLACENTA-DERIVED MESENCHYMAL STROMAL CELLS (PDMSCS) IN PHYSIOLOGICAL AND PREECLAMPTIC PREGNANCIES 123
Severe IUGR pregnancies have increased placental endoglin levels: hypoxic regulation via TGFbeta3 122
La Preeclampsia: dalla caratterizzazione clinico molecolare alla diagnosi precoce 120
Differential Expression of Vascular Endothelial Growth Factor (VEGF) and its Soluble Receptor sFlt-1 in Chronic Kidney Disease (CKD) and Preeclamptic Placentae. 119
Pregnancy, Proteinuria, Plant-Based Supplemented Diets and Focal Segmental Glomerulosclerosis: A Report on Three Cases and Critical Appraisal of the Literature. 118
Methodological approach to the 3D ultrasound reconstruction of human fetal thymus: a preliminary study. 117
A Systematic Review on Materno-Foetal Outcomes in Pregnant Women with IgA Nephropathy: A Case of "Late-Maternal" Preeclampsia? 117
Assessment of brain vascularization and blood flow in human fetus using quantitative three-dimensional power Doppler sonography 112
Fetal cerebral ventriculomegaly: outcome in 176 cases 111
Preeclampsia (PE) or Chronic Kidney Disease (CKD): Are soluble Fms-like Tyrosine Kinase-1 (sFlt-1) and Placental Growth Factor (PlGF) Suitable Biomarkers for Differential Diagnosis? 111
Totale 21.755
Categoria #
all - tutte 106.206
article - articoli 0
book - libri 0
conference - conferenze 26.203
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.409


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.825 0 0 0 0 0 1.504 840 604 806 517 357 197
2020/20214.743 467 209 369 235 421 291 361 233 639 504 331 683
2021/20226.220 353 413 458 537 448 331 505 497 375 384 799 1.120
2022/20236.722 697 503 181 657 612 1.711 575 367 705 149 372 193
2023/20243.020 373 574 166 193 227 252 151 204 51 182 254 393
2024/20253.664 83 504 284 794 1.751 248 0 0 0 0 0 0
Totale 41.389